IDWeek 2024丨儿童RSV预防：疫苗与单抗临床研究进展
编者按：呼吸道合胞病毒（RSV）作为一种对婴幼儿及免疫功能不全人群构成重大威胁的呼吸道病原体，近年来其疫苗和单克隆抗体的研发取得了诸多进展。在刚结束的2024年美国感染性疾病周（IDWeek 2024）上，多项关于儿童RSV防治的最新研究成果备受瞩目 ...
Allure on MSN1 天
Everything You Need to Know About the 2024 RSV Season
Experts share the official predictions for RSV surge levels in 2024 and 2025, why the levels change each year, and how to ...
首款！辉瑞疫苗再获FDA批准
▎药明康德内容团队编辑日前，辉瑞（Pfizer）宣布美国FDA已批准其呼吸道合胞病毒（RSV）疫苗Abrysvo（RSVpreF），用于预防18至59岁高风险个体因RSV引起的下呼吸道疾病（LRTD）。此前，该疫苗已获批用于60岁及以上的成人群体。根 ...
腾讯网3 天
辉瑞(PFE.US)RSV疫苗获FDA批准用于18-59岁年龄段人群接种
智通财经获悉，美国食品药品监督管理局(FDA)已批准辉瑞公司(PFE.US)的呼吸道合胞病毒(RSV)疫苗Abrysvo用于18至59岁下呼吸道疾病风险增加的人群。这些疾病包括肥胖、糖尿病、慢性阻塞性肺病、心力衰竭、慢性肾病和哮喘。扩大批准是基于3期 ...
GSK报告年轻成年人Arexvy疫苗数据令人鼓舞
全球医疗保健公司GSK plc (LSE/NYSE: GSK)今天宣布了正在进行的临床试验的初步数据,这些数据表明其呼吸道合胞病毒(RSV)疫苗Arexvy可能对更广泛的成年人群有效。 目前,Arexvy已在50多个国家获准用于60岁及以上人群,在美国和欧洲获准用于50-59岁高风险人群。新数据可能将RSV保护范围扩大到18-49岁有基础疾病的成年人和免疫功能低下的成年人。 III期临床试验(NC ...
CNET on MSN1 天
Is It the Flu, COVID, RSV or Allergies? Here Are Easy Ways to Tell
Besides the flu, other respiratory viruses such as respiratory syncytial virus (RSV) and COVID also tend to peak during the ...
Seniors Shielded: New RSV Vaccine Shows 80% Effectiveness
Recent findings from a multi-state study reveal that the RSV vaccine is approximately 80% effective in preventing severe ...
FiercePharma2 天
GSK answers Pfizer's RSV approval with data targeting matching nod in younger adults
“These promising data add to the evidence supporting GSK’s RSV vaccine and could help expand protection to more adults at ...
FDA批准辉瑞制药公司的RSV疫苗扩大使用范围至50岁以下成年人
纽约 - 辉瑞制药公司（NYSE: ...
FiercePharma1 天
Sanofi shrugs off potential RSV competition from Merck as Beyfortus grows sales 382%
On a Friday call with analysts, Sanofi execs pointed to an efficacy edge for its preventive and stressed that more ...
辉瑞制药：RSV 疫苗获美 FDA 批准
【10 月 23 日电，辉瑞制药 RSV 疫苗获 FDA 批准】 辉瑞制药针对呼吸道合胞体病毒的疫苗已获得美国食品药品管理局（FDA）批准。该疫苗用于 18 - 59 岁年龄段人群接种。
US FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease
The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract ...